Thanks for your honest response. I think that was pretty much the gist of the previous ihub sentiment. I agree and hope and don’t think it will come to this. If anything possibly something like misiu laid out where they license out HIV, GvHD, prognostic test and secure their financial future and keep cancer and future indications? I think that may be an acceptable risk once their balance sheet is much improved. Although they/RP has mentioned partnering with large cancer pharma companies.....I don’t recall the exact wording, but seemed along the lines of working with many to see how leronlimab compliments their current drugs to become safer and/or more effective (that was my understanding or take away from the conversation).